Aspect Partners’s Boston Scientific BSX Stock Holding History

Aspect Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.91K	Buy	115 +6	+6%	+$326	﹤0.01%	417
2026 Q1	$6.84K	Buy	109 +2	+2%	+$160	﹤0.01%	314
2025 Q4	$10.2K	Sell	107 -2	-2%	-$196	﹤0.01%	263
2025 Q3	$10.6K	Sell	109 -13	-11%	-$1.35K	﹤0.01%	296
2025 Q2	$13.1K	Buy	122 +32	+36%	+$3.24K	0.01%	255
2025 Q1	$9.08K	Hold	90	–	–	0.01%	273
2024 Q4	$8.04K	Sell	90 -162	-64%	-$14.3K	﹤0.01%	314
2024 Q3	$21.1K	Buy	252 +20	+9%	+$1.58K	0.01%	179
2024 Q2	$17.9K	Buy	232 +54	+30%	+$3.95K	0.01%	198
2024 Q1	$12.2K	Hold	178	–	–	0.01%	249
2023 Q4	$10.3K	Buy	+178	New	+$9.5K	0.01%	254

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Aspect Partners's BSX Position: Q2 2026 in Review

Aspect Partners increased its Boston Scientific (BSX) stake by 5.5% in Q2 2026, buying an estimated $326 and bringing the position to 115 shares worth $4.91K. The position accounts for ﹤0.01% of the portfolio, ranked #417.

Aspect Partners first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $21.1K in Q3 2024. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Aspect Partners held 115 shares of Boston Scientific worth $4.91K as of Q2 2026.
Aspect Partners bought 6 Boston Scientific shares in Q2 2026, an estimated $326.
Boston Scientific made up ﹤0.01% of Aspect Partners's portfolio in Q2 2026, its #417 holding.
Aspect Partners first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
Aspect Partners's Boston Scientific position peaked at $21.1K in Q3 2024.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.